LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 166 filers reported holding LEMAITRE VASCULAR INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $586,000 | +23.4% | 18,000 | 0.0% | 0.11% | +37.5% |
| Q2 2020 | $475,000 | +5.8% | 18,000 | 0.0% | 0.08% | -7.0% |
| Q1 2020 | $449,000 | -62.1% | 18,000 | -45.5% | 0.09% | -42.7% |
| Q4 2019 | $1,186,000 | +5.1% | 33,000 | 0.0% | 0.15% | -11.2% |
| Q3 2019 | $1,128,000 | +6.1% | 33,000 | -13.2% | 0.17% | +11.2% |
| Q2 2019 | $1,063,000 | -9.8% | 38,000 | 0.0% | 0.15% | -8.4% |
| Q1 2019 | $1,178,000 | +31.2% | 38,000 | 0.0% | 0.17% | +12.2% |
| Q4 2018 | $898,000 | -39.0% | 38,000 | 0.0% | 0.15% | -12.4% |
| Q3 2018 | $1,472,000 | +15.7% | 38,000 | 0.0% | 0.17% | +21.6% |
| Q2 2018 | $1,272,000 | -7.6% | 38,000 | 0.0% | 0.14% | -14.7% |
| Q1 2018 | $1,377,000 | +13.8% | 38,000 | 0.0% | 0.16% | +2.5% |
| Q4 2017 | $1,210,000 | -14.9% | 38,000 | 0.0% | 0.16% | -29.0% |
| Q3 2017 | $1,422,000 | -5.1% | 38,000 | -20.8% | 0.22% | -13.2% |
| Q2 2017 | $1,499,000 | +4.9% | 48,000 | -17.2% | 0.26% | -13.4% |
| Q1 2017 | $1,429,000 | – | 58,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ranger Investment Management | 948,480 | $43,649,050 | 3.24% |
| PERKINS CAPITAL MANAGEMENT INC | 37,586 | $1,730 | 1.83% |
| Bridge City Capital, LLC | 73,335 | $3,375 | 1.73% |
| Conestoga Capital Advisors, LLC | 1,841,501 | $84,745,876 | 1.59% |
| Copeland Capital Management, LLC | 1,277,478 | $58,790 | 1.55% |
| AWM Investment Company, Inc. | 230,000 | $10,584,600 | 1.53% |
| Summit Creek Advisors LLC | 236,303 | $10,874,664 | 1.48% |
| Values First Advisors, Inc. | 38,798 | $1,785,491 | 1.25% |
| CRAMER ROSENTHAL MCGLYNN LLC | 463,632 | $21,336,345 | 0.94% |
| GENEVA CAPITAL MANAGEMENT LLC | 893,312 | $41,110,218 | 0.92% |